ObeTherapy

is a French start-up biotech company dedicated to the discovery of new targets and the development of new drugs for obesity, hypercholesterolemia and type II diabetes based on lean and/or starvation phenotype.

ObeTherapy’s International conferences participation

GWAS: Big Data as a tool for Metabolic Syndrome Study. LifeScience R&D Big Data Leaders Forum Basel, Switzerland December 3-5, 2013.).

Thinking outside the box: For the identification of novel targets for diabetes treatment. 1st October to 2nd October 2013, London, United Kingdom.

Enteropeptidase: Identifying and Validating a Novel Target for the Treatment Obesity and Type II Diabetes by Rational Drug Design. 24-27th 9th IDF-WPR Congress & 4th AASD Scientific Meeting, Kyoto, Japan 2012(selected from abstract 15min).

Thinking outside the box: For the identification of novel targets for diabetes treatment. 6th Annual Diabetes Conference Evaluating the latest developments in managing diabetes and secondary complications in cardiovascular pathology. 25th – 26th April 2012, Thistle City Barbican, London, UK

Thinking outside the box: Considering new avenues of drug development that might lead to a breakthroughs in diabetes treatments. Clinical Trial Trials in Diabetes 28-29 February 2012, Arena, Amsterdam, Holland

Enteropeptidase: A gene associated with a lean human phenotype as a novel target for the treatment of obesity and type II diabetes. Emerging Therapeutic Strategies for Metabolic Disorders
10th to 11th November 2010, Copthorne Tara Hotel, London, United Kingdom. (Chairman of the conference)

Enteropeptidase: A Gene Associated to a Lean Human Phenotype as a Novel Target for the Treatment Obesity and Type II Diabetes.Diabetes Drug Discovery, Targeting Diabetes with Novel Therapeutics World Trade Center, Novemeber 3rd and 4th 2010 Boston, US

Identification of New Target for Obesity and Type ii Diabetes Treatment Based on Genes
Associated With Lean Phenotype in Human. Drug Discovery & Development Conference 2010, WDD European Summit 26-27th October Scandic Hotel Copenhagen, Denmark

Identification of New Target for Obesity and Type ii Diabetes Treatment Based on Genes
Associated With Lean Phenotype in Human. The 6th International Congress of Pathophysiology, Palais des Congré Montreal, Canada, 22-25 September 2010. (selected from abstract).

Identification of New Target for Obesity and TypeII Diabetes Treatment Based on Genes Associated with lean Phenotype….IDOF 2010 When Science Meets Health Cares. 21-23 October 2010 Hilton Athens Greece.(selected from abstract).

Identification of New Target for Obesity and Type ii Diabetes Treatment Based on Genes
Associated With Lean Phenotype in Human and Validation of the Target by Gene Inactivation in Mice. The 3rd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) Hilton Hotel, Prague, Czech Republic, May 13-16, 2010 (selected from abs

Look at ObeTherapy Biotechnology Presentation here